Community/Retail

Officials with the FDA have approved AbbVie’s upadacitinib (Rinvoq) 15 mg, once-daily oral Janus kinase (JAK) inhibitor, for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to methotrexate (MTX-IR).

Dennis Killian, PharmD, PhD, Director of Pharmacy Services, Peninsula Regional Medical Center, Salisbury, MD, discusses considerations when making the switch to IV robotics.

Suzanne Soliman, PharmD, founder of the Pharmacist Moms Group, talks about her hopes for the future of the online community.

Genomind is expanding its mental health genetic testing services with the addition of Genomind Professional PGx Express, which provides a more focused report and set of services to enhance the preexisting mental health genetic test.

Daniel Griffis, PharmD, pharmacist at the Rainbow Drug Store, sat down with Pharmacy Times and discussed the various services that the pharmacy provides.

Lindsay Davis, PharmD, BCPS, ASH-CHC, TTS and Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, both professors at t Midwestern University College of Pharmacy – Glendale, Glendale, AZ, discuss pharmacists as patient care providers, and managing patients taking anticoagulation medications.

Dennis Killian, PharmD, PhD, Director of Pharmacy Services, Peninsula Regional Medical Center, Salisbury, MD, discusses techniques to optimize the use of IV robotics in a hospital pharmacy setting.

Officials with the FDA issued a statement to clarify data accuracy issues with recently-approved gene therapy Zolgensma (onasemnogene abeparvovec-xioi, AveXis), a product intended to treat spinal muscular atrophy (SMA) in children under 2 years old.